Xie et al. found that overexpression of C2orf40 can suppress the activity of the AKT/mTOR signaling pathway and enhance the sensitivity of NPC cells to radiochemotherapy [6]. This evidence concerns the gene MTOR and nasopharyngeal carcinoma.